共 50 条
- [31] Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 StudyARTHRITIS & RHEUMATOLOGY, 2017, 69Bi, LiqiLi, YuhuiHe, LanXu, HujiGu, JieruoWang, GuochunZhang, ZhiyiLiu, YiBoehnlein, MarionDunkel, JochenShao, JingHarris, KristinaLi, Zhanguo
- [32] Efficacy and Safety of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 StudyARTHRITIS & RHEUMATOLOGY, 2016, 68Aletaha, DanielBingham, Clifton, IIITanaka, YoshiyaAgarwal, PrasheenKurrasch, ReginaTak, Paul-PeterPopik, Sharon
- [33] Correction to: Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritisClinical Rheumatology, 2020, 39 : 3527 - 3527Gerd BurmesterEdit DrescherPawel HrycajDavid ChienZhiying PanStanley Cohen
- [34] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-Week, Double-Blind, Randomized Placebo-Controlled StudyJOURNAL FUR MINERALSTOFFWECHSEL & MUSKULOSKELETTALE ERKRANKUNGEN, 2016, 23 (02): : 60 - 60Lunzer, R.
- [35] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled StudyJOURNAL OF RHEUMATOLOGY, 2016, 43 (03) : 504 - 511Tanaka, YoshiyaEmoto, KahakuCai, ZhihongAoki, TakehiroSchlichting, DouglasRooney, TerenceMacias, William
- [36] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind StudyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232Zhang, JianzhongGu, JunZheng, JieZheng, MinWang, GangGu, YihuaOkun, Martin
- [37] SUMMACTA: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF TOCILIZUMAB SUBCUTANEOUS (SC) VERSUS TOCILIZUMAB INTRAVENOUS (IV), IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS (RA)INTERNAL MEDICINE JOURNAL, 2013, 43 : 13 - 13Hall, S.Bird, P.Rischmueller, M.Rubbert-Roth, A.Cantagrel, A.Leszczynski, P.Feldman, D.Rangaraj, M.Roane, G.Ludivico, C.Mysler, E.Rowell, L.Douglass, W.Burmester, G.
- [38] Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind studyANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (08) : 1567 - 1570Smolen, Josef S.Weinblatt, Michael E.van der Heijde, DesireeRigby, William F. C.van Vollenhoven, RonaldBingham, Clifton O., IIIVeenhuizen, MelissaGill, AnneZhao, FangyiKomocsar, Wendy J.Berclaz, Pierre-YvesOrtmann, RobertLee, Chin
- [39] Efficacy and safety of risankizumab vs methotrexate in patients with moderate-to-severe plaque psoriasis: Results from the 28-week randomized, double-blind period of an ongoing phase 3 study in BrazilJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB88 - AB88Cestari, Tania F.Souza, Cacilda daSilvaAzulay-Abulafia, LunaRomiti, RicardoCarvalho, Andre V. E.Silva de Castro, Caio CesarMarques, Silvio AlencarAntonio, Joao RobertoFabricio, LincolnKalabic, JasminaOyafuso, Luiza Keiko
- [40] A PHASE 3, RANDOMIZED, DOUBLE-BLIND, ACTIVE COMPARATOR STUDY OF THE EFFICACY AND SAFETY OF BOW015, A BIOSIMILAR INFLIXIMAB, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS ON STABLE METHOTREXATE DOSESANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 64 - 64Kay, J.Chopra, A.Chandrashekara, S.Olakkengil, D. J.Bhojani, K. S.Bhatia, G.Rathi, G.Thomas, M.Maroli, S.Thomson, E. S.Shneyer, L.Wyand, M. S.